Posts Tagged: "Boston Scientific"

CAFC Remands Medinol Patent Suit Against Cordis After SCOTUS Overturns Laches Finding

On Thursday, April 20th, the Court of Appeals for the Federal Circuit issued a decision in Medinol Ltd. v. Cordis Corporation et. al. which vacated and remanded a lower court’s ruling that claims of patent infringement alleged by Israeli pharmaceutical firm Medinol were barred by the equitable defense of laches. The Federal Circuit’s decision comes after the U.S. Supreme Court overturned the Federal Circuit’s previous precedence on laches as an equitable defense in SCA Hygiene Products v. First Quality Baby Products, decided last year. The case was decided by a panel consisting of Circuit Judges Timothy Dyk, Jimmie Reyna and Kara Stoll.

Steve Brachmann

May 6, 2018

European Patent Office grants more patents to US companies than ever before

The number of patents granted to US companies by the European Patent Office (EPO) grew by 46.7% in 2016, the highest increase in ten years, and a new record high. Last year US companies were granted 21,939 patents by the EPO (2015: 14,955).

Press Releases

March 7, 2017

Boston Scientific patents implantable devices for treating depression

The Boston Scientific Corporation (NYSE: BSX), officially headquartered in Marlborough, MA, is a developer and manufacturer of medical device products. Its devices are used in a diverse set of medical specialities including neuromodulation, vascular surgery, oncology, radiology and interventional cardiology. Boston Scientific’s research and development goals are aided by a network of three innovation centers for developing products as well…

Steve Brachmann

February 16, 2015